DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

TRIUMPH-1

Retatrutide

Without diabetes · 80 weeks · n=2,339

Randomised, double-blind, placebo-controlled. Treatment-regimen estimand. The paper reports 2,339 randomised participants and the registry lists 2,335 enrolled.

Mean body weight change at 80 weeks
  • Retatrutide 4 mg−17.6%
  • Retatrutide 9 mg−23.7%
  • Retatrutide 12 mg−25.0%
  • Placebo−3.9%
Published paper PubMed abstract NCT05929066

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.